Bayer sues Watson to block copycat Beyaz; Sun Pharma posts big rise in profits, sales;

@FiercePharma: More fallout from Ben Venue's manufacturing snafu: Childhood leukemia drug may run out w/in 2 weeks--NYT. News | Follow @FiercePharma

> A Bayer ($BAY) unit is suing Watson Pharmaceuticals ($WPI) over the generics maker's bid to knock off the birth-control pill Beyaz. More

> India's Sun Pharmaceutical beat analyst estimates with a 91% increase in profits for its fiscal third quarter; sales grew by 37%. Report

> The FDA issued guidelines for safe production of the bloodthinner heparin, which was caught up in a contamination scandal four years ago. Story

> AmerisourceBergen CFO Michael DiCandilo is leaving "to pursue other interests," with controller Tim Guttman stepping in as interim CFO until a replacement is found. News

> Bristol-Myers Squibb ($BMY) wrapped up its $26-per-share tender offer for Inhibitex ($INHX) with about 91% of the outstanding stock. Article

> The Russian pharmaceutical market is expected to continue its "stupendous growth" through 2013, the market resesarch firm RNCOS said. Report

> The Obama administration's compromise on birth control puts insurers on the hook for covering the cost of their members' free contraception. Story

Biotech News

@FierceBiotech: Scientists at JHU have developed a virtual tool, Pyromaker, that can aid in analysis of complex genetic mutations. Release | Follow @FierceBiotech

@JohnCFierce: Last week's headlines on mouse study and bexarotene inspired some Alzheimer's patients to ask for an Rx. More | Follow @JohnCFierce

@RyanMFierce: A German drug data firm got slammed for potential privacy violations after selling Big Pharma groups raw script data. Story | Follow @RyanMFierce

@FierceMedDev: J&J could invest in Salt Lake City-based Coherex Medical (Update) (@deseretnews). News | Follow @FierceMedDev

> U.K. charities campaign to modify pricey regs in trials directive. Article

> Hungry Valeant snags Eyetech in ongoing buyout spree. News

IT News

> Belgian researchers access CLC bio's sequence analysis software. Story

> EMC to found Russian cloud computing, 'Big Data' hub. More

> Eagle Genomics, Cycle Computing win bid to develop bioinformatics solutions. News

> CRO ESTERN, Nextrials sign software agreement. Article

> German drug data outfit slammed for potential privacy breach. Item

Medical Device News

> What's next for Stryker after MacMillan's exit? Story

> Nodality, UCB Pharma ink multiyear companion diagnostics deal. Piece

> Is medical tech the answer for Sony? Item

> Court upholds $371M patent decision against W.L. Gore, favoring Bard. Story

> EU seeks greater oversight after breast implant hysteria. Report

> Rogers, Markey seek new life for unpopular pediatric device rule. Article

And Finally... GlaxoSmithKline ($GSK) is sifting traditional Chinese medicine for principles handy to contemporary R&D. More

Suggested Articles

BMS' Opdivo-Yervoy combo is playing in an increasingly crowded space. But the company is leaning on new long-term data to set its regimen apart.

GSK and Alcon have pulled off prescription-to-OTC switches in hopes of giving aging brands Voltaren and Pataday a boost.

Sanofi didn't hesitate to enter Zika vaccine R&D, and despite the associated scandal, the company is again jumping into emerging disease vaccine R…